Lingua: Inglese
Editore: Marvel Comics Group, New York, NY, USA, 1988
ISBN 10: 0871354837 ISBN 13: 9780871354839
Da: Comic World, Steinbach, MB, Canada
Prima edizione
EUR 35,06
Quantità: 1 disponibili
Aggiungi al carrelloPictorial Illustrated Cover. Condizione: Near Fine. Doug Beekman painted cover; Art by; John Buscema, Danny Bulandi, Ricado Villamonte, Armando Gil and Dave Simons; (illustratore). First Edition By This Publisher. 100 pages including covers; Published by Marvel Comics Group, New York, NY, USA, 1988; 1st Printing; Softcover, Trade Paperback, Graphic Novel; 330 Grams; As the Red Terror, a bizarre, magical dark force whose victims disappear without a trace, descends upon Aquilonia, King Conan sets out to destroy its source, evil, conquest-hungry sorcerer-priests from across the sea; This book was written as the definite end to the saga of Conan. In his mid-sixties, longtime king of Aquilonia, his beloved wife having died and his son now an adult, Conan has become weary of his now dull existence as a monarch. ROY THOMAS Adaption of the L. Sprague de Camp and Lin Cater story (based characters created by Robert E. Howard); Doug Beekman painted cover; Art by; John Buscema, Danny Bulandi, Ricado Villamonte, Armando Gil and Dave Simons; Light Scuffing to cover; Moderate Rubbing Wear to back cover, Size: 4to - over 9¾" - 12" tall. Book.
Lingua: Inglese
Editore: American Association of Pharmaceutical Scientists., 2005
ISBN 10: 0971176736 ISBN 13: 9780971176737
Da: Antiquariat Thomas Haker GmbH & Co. KG, Berlin, Germania
Membro dell'associazione: GIAQ
EUR 20,96
Quantità: 1 disponibili
Aggiungi al carrelloHardcover. Condizione: Wie neu. 500 S., Like new. Shrink wrapped. / Wie neu. In Folie verschweißt. Sprache: Englisch Gewicht in Gramm: 1220.
Editore: Souvenir Magazine, Palm Springs, 1955
Prima edizione
Softcover. Condizione: Very Good. First Edition; First Printing. Very Good paperback with minor cover edgewear. Contributors other than the editors listed on the contents page: Charles F. Buddy, Daniel O'Donovan, John Power, Maxine Whiteside, Oliver Jaynes, George Wheeler, Eddie Welch, Jimmy Durante, Hildy Crawford, Harry Oliver, Mousie Powell, Danny Thomas, Percy Whiteside. Unpaginated. [dp50 1210]. ; Shlf [Ntsp]; 8vo 8" - 9" tall; Unpaginated pages.
Da: WeBuyBooks, Rossendale, LANCS, Regno Unito
EUR 75,57
Quantità: 1 disponibili
Aggiungi al carrelloCondizione: Good. Most items will be dispatched the same or the next working day. A copy that has been read but remains in clean condition. All of the pages are intact and the cover is intact and the spine may show signs of wear. The book may have minor markings which are not specifically mentioned. Ex library copy with usual stamps & stickers.
Da: SpringBooks, Berlin, Germania
Prima edizione
EUR 69,67
Quantità: 1 disponibili
Aggiungi al carrelloHardcover. Condizione: As New. 1. Auflage. unread, like new - will be dispatched immediately.
Da: Buchpark, Trebbin, Germania
EUR 30,91
Quantità: 1 disponibili
Aggiungi al carrelloCondizione: Sehr gut. Zustand: Sehr gut | Seiten: 344 | Sprache: Englisch | Produktart: Bücher | In this volume, the specific challenges and problems facing the evaluation of new oncology agents are explored with regards to pharmacokinetic, pharmacodynamic modeling and clinical pharmacology development strategies. This book delivers, with an emphasis on the oncology therapeutic area, the goals set in the first three volumes: namely ¿ to provide clinical pharmacologists practical insights for the application of pharmacology, pharmacokinetics and pharmacodynamics for new drug development strategies. Pharmacokinetic-pharmacodynamic concepts for tyrosine kinases, the evaluation of cardiac repolarization prolongation through QTc interval effects, efficacy- and safety-response analyses to support new drug approvals, clinical and preclinical tumor growth modeling, and flat- vs weight-based dose selection are showcased from an oncology clinical pharmacologist¿s point-of-view. Oncology development strategies are surveyed for new FDA-approvals to identify patterns in expectations at time of first approval. The special considerations necessary to address combination drug development, metronomics, biosimilars and breakthrough therapies are also presented.
Da: HPB-Red, Dallas, TX, U.S.A.
hardcover. Condizione: Good. Connecting readers with great books since 1972! Used textbooks may not include companion materials such as access codes, etc. May have some wear or writing/highlighting. We ship orders daily and Customer Service is our top priority!
Lingua: Inglese
Editore: American Association of Pharmaceutical Scientists, 2005
ISBN 10: 0971176744 ISBN 13: 9780971176744
Da: BennettBooksLtd, Los Angeles, CA, U.S.A.
Hardcover. Condizione: New. In shrink wrap. Looks like an interesting title!
Da: GreatBookPrices, Columbia, MD, U.S.A.
Condizione: New.
Da: GreatBookPrices, Columbia, MD, U.S.A.
Condizione: New.
Da: Ria Christie Collections, Uxbridge, Regno Unito
EUR 200,04
Quantità: Più di 20 disponibili
Aggiungi al carrelloCondizione: New. In.
Da: Ria Christie Collections, Uxbridge, Regno Unito
EUR 200,04
Quantità: Più di 20 disponibili
Aggiungi al carrelloCondizione: New. In.
Da: GreatBookPrices, Columbia, MD, U.S.A.
Condizione: As New. Unread book in perfect condition.
Da: GreatBookPrices, Columbia, MD, U.S.A.
Condizione: As New. Unread book in perfect condition.
Da: Ria Christie Collections, Uxbridge, Regno Unito
EUR 224,33
Quantità: Più di 20 disponibili
Aggiungi al carrelloCondizione: New. In.
Da: GreatBookPrices, Columbia, MD, U.S.A.
Condizione: New.
Da: GreatBookPrices, Columbia, MD, U.S.A.
Condizione: New.
Da: Ria Christie Collections, Uxbridge, Regno Unito
EUR 224,33
Quantità: Più di 20 disponibili
Aggiungi al carrelloCondizione: New. In.
Lingua: Inglese
Editore: American Association of Pharmaceutical Scientists, 2005
ISBN 10: 0971176744 ISBN 13: 9780971176744
Da: Ria Christie Collections, Uxbridge, Regno Unito
EUR 224,33
Quantità: Più di 20 disponibili
Aggiungi al carrelloCondizione: New. In English.
Lingua: Inglese
Editore: American Association of Pharmaceutical Scientists, 2005
ISBN 10: 0971176744 ISBN 13: 9780971176744
Da: GreatBookPrices, Columbia, MD, U.S.A.
Condizione: New.
Da: preigu, Osnabrück, Germania
EUR 166,90
Quantità: 5 disponibili
Aggiungi al carrelloTaschenbuch. Condizione: Neu. Pharmacokinetics in Drug Development | Problems and Challenges in Oncology, Volume 4 | Peter L. Bonate (u. a.) | Taschenbuch | xii | Englisch | 2018 | Springer | EAN 9783319818054 | Verantwortliche Person für die EU: Springer Verlag GmbH, Tiergartenstr. 17, 69121 Heidelberg, juergen[dot]hartmann[at]springer[dot]com | Anbieter: preigu.
Lingua: Inglese
Editore: American Assoc. of Pharm. Scientists, 2005
ISBN 10: 0971176736 ISBN 13: 9780971176737
Da: Mispah books, Redhill, SURRE, Regno Unito
EUR 215,98
Quantità: 1 disponibili
Aggiungi al carrelloHardcover. Condizione: Like New. LIKE NEW. SHIPS FROM MULTIPLE LOCATIONS. book.
Da: GreatBookPrices, Columbia, MD, U.S.A.
Condizione: As New. Unread book in perfect condition.
Lingua: Inglese
Editore: American Association of Pharmaceutical Scientists, 2005
ISBN 10: 0971176744 ISBN 13: 9780971176744
Da: GreatBookPrices, Columbia, MD, U.S.A.
Condizione: As New. Unread book in perfect condition.
Da: Books Puddle, New York, NY, U.S.A.
Condizione: New. pp. 310.
Da: preigu, Osnabrück, Germania
EUR 184,85
Quantità: 5 disponibili
Aggiungi al carrelloTaschenbuch. Condizione: Neu. Pharmacokinetics in Drug Development | Advances and Applications, Volume 3 | Peter L. Bonate (u. a.) | Taschenbuch | xii | Englisch | 2016 | Springer | EAN 9781489977991 | Verantwortliche Person für die EU: Springer Verlag GmbH, Tiergartenstr. 17, 69121 Heidelberg, juergen[dot]hartmann[at]springer[dot]com | Anbieter: preigu.
Lingua: Inglese
Editore: Springer International Publishing, Springer International Publishing, 2016
ISBN 10: 3319390511 ISBN 13: 9783319390512
Da: AHA-BUCH GmbH, Einbeck, Germania
EUR 192,59
Quantità: 1 disponibili
Aggiungi al carrelloBuch. Condizione: Neu. Druck auf Anfrage Neuware - Printed after ordering - In this volume, the specific challenges and problems facing the evaluation of new oncology agents are explored with regards to pharmacokinetic, pharmacodynamic modeling and clinical pharmacology development strategies. This book delivers, with an emphasis on the oncology therapeutic area, the goals set in the first three volumes: namely - to provide clinical pharmacologists practical insights for the application of pharmacology, pharmacokinetics and pharmacodynamics for new drug development strategies. Pharmacokinetic-pharmacodynamic concepts for tyrosine kinases, the evaluation of cardiac repolarization prolongation through QTc interval effects, efficacy- and safety-response analyses to support new drug approvals, clinical and preclinical tumor growth modeling, and flat- vs weight-based dose selection are showcased from an oncology clinical pharmacologist's point-of-view. Oncology development strategies are surveyed for new FDA-approvals to identify patterns in expectations at time of first approval. The special considerations necessary to address combination drug development, metronomics, biosimilars and breakthrough therapies are also presented.
Da: AHA-BUCH GmbH, Einbeck, Germania
EUR 201,36
Quantità: 1 disponibili
Aggiungi al carrelloTaschenbuch. Condizione: Neu. Druck auf Anfrage Neuware - Printed after ordering - In this volume, the specific challenges and problems facing the evaluation of new oncology agents are explored with regards to pharmacokinetic, pharmacodynamic modeling and clinical pharmacology development strategies. This book delivers, with an emphasis on the oncology therapeutic area, the goals set in the first three volumes: namely - to provide clinical pharmacologists practical insights for the application of pharmacology, pharmacokinetics and pharmacodynamics for new drug development strategies. Pharmacokinetic-pharmacodynamic concepts for tyrosine kinases, the evaluation of cardiac repolarization prolongation through QTc interval effects, efficacy- and safety-response analyses to support new drug approvals, clinical and preclinical tumor growth modeling, and flat- vs weight-based dose selection are showcased from an oncology clinical pharmacologist's point-of-view. Oncology development strategies are surveyed for new FDA-approvals to identify patterns in expectations at time of first approval. The special considerations necessary to address combination drug development, metronomics, biosimilars and breakthrough therapies are also presented.
Da: Books Puddle, New York, NY, U.S.A.
Condizione: New. pp. 331.
Da: Kennys Bookshop and Art Galleries Ltd., Galway, GY, Irlanda
EUR 257,57
Quantità: 15 disponibili
Aggiungi al carrelloCondizione: New. A guide to pharmacokinetics (PK) and its role in drug development. Suitable for graduate level students and scientists in the areas of clinical pharmacology and PK, it intends to fill a gap between the academic science and the practical application of that knowledge in drug development. Editor(s): Bonate, Peter L.; Howard, Danny R. Num Pages: 640 pages, 74 black & white tables, biography. BIC Classification: MMG. Category: (P) Professional & Vocational. Dimension: 254 x 178 x 34. Weight in Grams: 1324. . 2005. Hardback. . . . .